Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.

Revenue
+3.07%
EPS
−13.5%
Free cash flow
+29.8%
Total debt
−7.50%

Quarter to September 2026, against a year earlier

105.28 1.57 −1.47%
Market cap
$20.4B
P/E
26.9×
Fwd P/E
18.9×
Dividend yield
0.90%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Piotroski F-Score

+8 more TTM periods

6 6 6 6
ROE
5.60% 6.07% 6.41% 6.02%
ROA
3.17% 3.39% 3.53% 3.26%
ROIC
3.50% 3.74% 3.82% 3.66%
Return on Tangible Assets
14.87% 17.66% 18.67% 19.49%
Average Days of Receivables
75.58 75.03 75.91 77.34
Free Cash Flow per Share
5.44 5.17 5.39 5.86
Free Cash Flow
1,077.30 1,008.10 1,036.50 1,116.20
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026